Treatment of disease with paf-acether antagonists and procedure determining their efficacy

摘要

The present invention is directed to the treatment of a disease caused by an amount of pathogenic LA-paf in lipoproteins and cells comprising administering to a subject requiring the treatment an effective amount of a paf-acether antagonist.